Stock Price
41.75
Daily Change
-0.25 -0.60%
Monthly
5.40%
Yearly
54.69%
Q2 Forecast
41.02

Xoma reported $-1.59 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Agenus USD -0.3 0.84 Dec/2025
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Ardelyx USD -0.15 0.15 Mar/2026
aTyr Pharma USD 0.53 0.8 Dec/2025
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Celldex Therapeutics USD -1.18 0.04 Mar/2026
Curis USD 1.23 3.26 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Incyte USD 1.81 0.01 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Prothena USD 0.6 1.06 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Xoma USD -1.59 2.43 Sep/2024